A rare combination of arterio-portal fistula and portosystemic shunt. Endovascular treatment
- Authors: Garbuzov R.V.1, Polyaev Y.A.1, Mylnikov I.A.1
-
Affiliations:
- Russian Children’s Clinical Hospital — Pirogov Russian National Research Medical University
- Issue: Vol 29, No 1 (2025)
- Pages: 41-48
- Section: CASE REPORTS
- Submitted: 23.09.2024
- Accepted: 11.02.2025
- Published: 17.03.2025
- URL: https://jps-nmp.ru/jour/article/view/807
- DOI: https://doi.org/10.17816/ps807
- ID: 807
Cite item
Abstract
BACKGROUND: Portosystemic shunts (PSS) is a rare malformation in which there is an abnormal connection between the portal system and the systemic circulation. Arterio-portal fistulas (APF) are arterio-venous connections between the arteries of the ventral trunk system and the portal vein. Hepatopulmonary syndrome) is defined by the respiratory dysfunction due to the defect in arterial oxygenation induced by the dilatation of intrapulmonary vessels associated with liver disease.
CLINICAL CASE DESCRIPTION: In our clinic, we treated endovascularly a 10.5-y.o. patient with a rare combination of congenital portosystemic shunt (CPSS) and congenital APF complicated by Hepatopulmonary syndrome. The treatment was performed in several stages. The first stage was APF occlusion. The second stage was a balloon occlusion test. The third stage was PSS occlusion. In the postoperative period, there were signs of portal hypertension (PH), that is why the anticoagulant therapy was administered which resulted in PH symptoms regression.
CONCLUSION: In case of the combined arterio-portal fistula and congenital portosystemic shunt, it is necessary, first, to occlude APF, then to perform the balloon occlusion test, and then -if there are well developed intrahepatic branches of the portal vein- to perform PSS occlusion. In the postoperative period, anticoagulant therapy is recommended for preventive purposes.
Full Text

About the authors
Roman V. Garbuzov
Russian Children’s Clinical Hospital — Pirogov Russian National Research Medical University
Email: 9369025@mail.ru
ORCID iD: 0000-0002-5287-7889
SPIN-code: 7590-2400
MD, Dr. Sci. (Medicine)
Россия, MoscowYuri A. Polyaev
Russian Children’s Clinical Hospital — Pirogov Russian National Research Medical University
Email: polyaev@inbox.ru
ORCID iD: 0000-0002-9554-6414
SPIN-code: 7587-9843
MD, Dr. Sci. (Medicine), Professor
Россия, MoscowIvan A. Mylnikov
Russian Children’s Clinical Hospital — Pirogov Russian National Research Medical University
Author for correspondence.
Email: dr.mylnikov@mail.ru
ORCID iD: 0009-0005-0898-5355
Россия, Moscow
References
- Garbuzov RV, Polyaev YuA, Stepanov AE, Mylnikov AA. Abernathy malformations in children. Experience in endovascular and surgical treatment. Detskaya khirurgiya (Russian Journal of Pediatric Surgery). 2020;24(2):71–77. doi: 10.18821/1560-9510-2020-24-2-71-77
- Степанов А.Э., Сухов М.Н., Васильев К.Г., и др. Врожденные портосистемные шунты: опыт хирургического лечения. Российский вестник детской хирургии, анестезиологии и реаниматологии. 2022;12(4):473–487. doi: 10.17816/psaic1295
- Franchi-Abella S, Gonzales E, Ackermann O, et al. International Registry of Congenital Portosystemic Shunt members. Congenital portosystemic shunts: diagnosis and treatment. Abdom Radiol (NY). 2018;43(8):2023–2036. doi: 10.1007/s00261-018-1619-8
- Abernethy J. Account of two instances of uncommon formation in the viscera of the human body: from the philosophical transactions of the Royal Society of London. Med Facts Obs. 1797;7:100–108.
- Morgan G, Superina R. Congenital absence of the portal vein: two cases and a proposed classification system for portasystemic vascular anomalies. J Pediatr Surg. 1994;29(9):1239–1241. doi: 10.1016/0022-3468(94)90812-5
- Lautz TB, Tantemsapya N, Rowell E, Superina RA. Management and classification of type II congenital portosystemic shunts. J Pediatr Surg. 2011;46(2):308–314. doi: 10.1016/j.jpedsurg.2010.11.009
- Kanazawa H, Nosaka S, Miyazaki O, et al. The classification based on intrahepatic portal system for congenital portosystemic shunts. J Pediatr Surg. 2015;50(4):688-695. doi: 10.1016/j.jpedsurg.2015.01.009
- Rodríguez-Roisin R, Krowka MJ, Hervé P, Fallon MB. ERS Task Force Pulmonary-Hepatic Vascular Disorders (PHD) Scientific Committee. Pulmonary-Hepatic vascular Disorders (PHD). Eur Respir J. 2004;24(5):861–880. doi: 10.1183/09031936.04.00010904
- Imamura H, Momose T, Kitabayashi H, et al. Pulmonary hypertension as a result of asymptomatic portosystemic shunt. Jpn Circ J. 2000;64(6):471–473. doi: 10.1253/jcj.64.471
- Guzman EA, McCahill LE, Rogers FB. Arterioportal fistulas: introduction of a novel classification with therapeutic implications. J Gastrointest Surg. 2006;10(4):543–550. doi: 10.1016/j.gassur.2005.06.022
- Van Way CW, CJ, Riddell DH, Foster JH. Arteriovenous fistula in the portal circulation. Surgery. 1971;70:876–890.
- Vauthey JN, Tomczak RJ, Helmberger T, et al. The arterioportal fistula syndrome: clinicopathologic features, diagnosis, and therapy. Gastroenterology. 1997;113(4):1390–1401. doi: 10.1053/gast.1997.v113.pm9322535
- Chae EJ, Goo HW, Kim SC, Yoon CH. Congenital intrahepatic arterioportal and portosystemic venous fistulae with jejunal arteriovenous malformation depicted on multislice spiral CT. Pediatr Radiol. 2004;34(5):428–431. doi: 10.1007/s00247-003-1093-4
Supplementary files
